Institutional Ownership
Celldex Therapeutics Inc New
CUSIP 15117B202COM NEWCLDXQ1 2026
13D / 13G Filings
63
Schedule 13D/13G on record
Beneficial Filers
25
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
221
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
63 filings · latest Mar 10, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 10, 2026 | Point72 Asset Management, L.P. | 13G/A | 2.6% | 1.76M | SEC |
| 2 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | 12.2% | 8.08M | SEC |
| 3 | Feb 9, 2026 | State Street Corporation | 13G | 5.1% | 3.40M | SEC |
| 4 | Nov 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 3.03M | SEC |
| 5 | Nov 14, 2025 | Bellevue Group AG | 13G | 5.4% | 3.62M | SEC |
| 6 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 3.6% | 2.38M | SEC |
| 7 | Nov 7, 2025 | Wellington Management Group LLP | 13G/A | 11.1% | 7.39M | SEC |
| 8 | Aug 14, 2025 | Eventide Asset Management, LLC | 13G/A | 2.0% | — | SEC |
| 9 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 7.9% | 5.23M | SEC |
| 10 | Jul 10, 2025 | Point72 Asset Management, L.P. | 13G | 6.7% | 4.46M | SEC |
53 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Celldex Therapeutics Inc New.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Wellington Management Group LLP | 8.56M | $271.54M |
| 2 | Kynam Capital Management, LP | 5.84M | $185.26M |
| 3 | Blackrock, Inc. | 5.37M | $170.33M |
| 4 | Fmr LLC | 3.75M | $118.92M |
| 5 | Point72 Asset Management, L.P. | 3.23M | $102.45M |
| 6 | State Street Corp | 2.80M | $88.95M |
| 7 | Commodore Capital LP | 2.70M | $85.54M |
| 8 | Eversept Partners, LP | 1.79M | $56.72M |
| 9 | Geode Capital Management, LLC | 1.69M | $53.56M |
| 10 | Braidwell LP | 1.36M | $43.01M |